17 Mar 2023 by admin in UncategorizedComments China’s NMPA Clears Phase 3 IND Application for Alebund Pharmaceutical’s AP301, a New-generation Iron-based Phosphate Binder, to Treat Hyperphosphatemia in Dialysis Patients
28 Feb 2023 by admin in UncategorizedComments Oricell Closes $45M Series B1 Financing to Expand Development of Key Products
28 Feb 2023 by admin in UncategorizedComments Eluminex Biosciences Closes $40+ Million Series B Financing
14 Feb 2023 by admin in UncategorizedComments Eluminex Announces Completion of Enrollment in Part A of the CLARITY Study
31 Jan 2023 by admin in UncategorizedComments Oricell Publishes Data from POLARIS Clinical Study Evaluating OriCAR- 017 in the Treatment of RRMM
31 Jan 2023 by admin in UncategorizedComments Crescendo Biologics is category winner for Biopharma and Vaccines in 2023 UK DIT Life Sciences Innovator Showcase
26 Jan 2023 by admin in UncategorizedComments Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Higher-Risk Myelodysplastic Syndrome
